Loading...
XNYS
COR
Market cap58bUSD
Jul 09, Last price  
302.46USD
1D
-2.30%
1Q
-5.72%
Jan 2017
286.83%
Name

Amerisourcebergen Corp

Chart & Performance

D1W1MN
XNYS:COR chart
P/E
37.86
P/S
0.18
EPS
7.99
Div Yield, %
0.74%
Shrs. gr., 5y
-0.95%
Rev. gr., 5y
11.09%
Revenues
321.33b
+9.31%
61,203,145,00066,074,312,00070,189,733,00071,759,990,00077,953,979,00080,217,558,00079,489,596,00087,959,167,000119,569,127,000135,961,803,000146,849,686,000153,143,826,000167,939,635,000179,589,121,000189,893,926,000213,988,843,000238,587,006,000262,173,411,000293,958,599,000321,332,819,000
Net income
1.55b
+2.99%
467,714,000469,167,000250,559,000503,397,000636,748,000706,624,000718,986,000433,707,000276,484,000-134,887,0001,427,929,000414,484,0001,658,405,000855,365,000-3,399,558,0001,539,932,0001,698,820,0001,745,293,0001,509,120,0001,554,169,000
CFO
3.88b
+11.20%
807,265,0001,207,904,000737,069,000783,763,0001,108,624,0001,167,948,0001,305,449,000788,125,0001,463,153,0003,920,379,0003,178,497,0001,489,007,0001,411,388,0002,344,023,0002,207,040,0002,666,586,0002,703,088,0003,911,334,0003,484,685,0003,875,120,000
Dividend
Nov 14, 20250.6 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AmerisourceBergen Corporation (ABC) operates as a prominent global distributor and procurer of pharmaceutical products. Its core business is structured around two main segments. The Pharmaceutical Distribution division is responsible for the extensive supply of both brand-name and generic medicines, alongside over-the-counter health items, and equipment for home healthcare. This segment extends its services to a wide array of healthcare entities, including acute care hospitals, integrated health systems, independent and chain retail pharmacies, mail-order drug providers, medical clinics, and facilities offering long-term care or alternative site pharmacy services. Beyond product distribution, it offers comprehensive pharmacy management and staffing solutions, consulting expertise, and specialized supply chain software tailored for both retail and institutional healthcare settings. Furthermore, ABC provides bespoke packaging services. This division also manages the distribution of vital plasma and blood products, various injectable pharmaceuticals, vaccines, and other specialty medications. It furnishes support services primarily to physicians specializing in areas like oncology, as well as to hospitals and dialysis centers, while also delivering critical data analytics, outcomes research, and supplementary services to biotechnology and pharmaceutical manufacturers. The Other segment encompasses a range of integrated services for manufacturers, spanning clinical trial assistance, post-approval support, and commercialization strategies for new products. It also manages specialized transportation and logistics crucial for the biopharmaceutical sector. Additionally, this segment supplies pharmaceuticals, vaccines, parasiticides, diagnostic tools, and micro feed ingredients to both companion animal and production animal markets. It further aids manufacturers by providing sales force services aimed at generating demand. AmerisourceBergen Corporation was established in 2001 and maintains its headquarters in Conshohocken, Pennsylvania.
IPO date
May 28, 1996
Employees
480
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT